HZHaiyang Zhang

Haiyang Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haiyang Zhang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Front Cover

    by Lianfei Fang, Yinwei Li, Yining Wei, Haiyang Zhang, Ming Lin, Chao Shen, Surui Sheng, Yue He, Zhifeng Shi, Huifang Zhou

    The cover image is based on the article Optimizing Surgical Management of Craniofacial and Orbital Fibrous Dysplasia: A Multi‐Center Retrospective Study by Lianfei Fang et al., https://doi.org/10.1002/hed.70190 . image

  • Top Cited Papers

    The predictive, preventive, and personalised medicine of thyroid eye disease: a comprehensive guide to risk minimization

    by Haiyang Zhang, Lehan Yang, Runchuan Li, Rebecca Bahn, Haixia Guan, Huifang Zhou

    Thyroid eye disease (TED) is a prevalent autoimmune orbital disorder that significantly impairs visual function and appearance, adversely affecting patients’ quality of life. The development of effective preventive strategies is paramount to optimizing clinical outcomes and disease management. Within the paradigm of predictive, preventive, and personalised medicine (3PM), the identification of modifiable risk factors for TED and the formulation of individualized prevention protocols are critical for targeted risk minimization. However, despite advances in understanding TED pathogenesis, the susceptible populations of TED remain inadequately defined, resulting in generalized and often ineffective preventive measures. Furthermore, while several risk factors for TED development have been identified, particularly tobacco exposure, radioiodine treatment and thyroid dysfunction, their differential contributions across distinct disease courses (onset, progression, and recurrence) remain poorly elucidated. This review comprehensively summarizes current clinical evidence on susceptible populations for TED and classifies modifiable risk factors into five categories: physical and chemical factors, endocrine and autoimmune factors, metabolic and nutritional factors, social and psychological factors, and other factors, with updated clinical evidence of their impacts on disease course. Building upon contemporary clinical evidence, we present a stratified strategy for TED prevention spanning onset, progression, and recurrence that tailored to disease phase-specific vulnerabilities. Early identification and mitigation of modifiable risk factors are pivotal to transitioning TED management from reactive medical services to a 3PM paradigm, ultimately reducing disease incidence, improving clinical outcomes and patients’ quality of life.


  • Optimizing Surgical Management of Craniofacial and Orbital Fibrous Dysplasia: A Multi‐Center Retrospective Study

    by Lianfei Fang, Yinwei Li, Yining Wei, Haiyang Zhang, Ming Lin, Chao Shen, Surui Sheng, Yue He, Zhifeng Shi, Huifang Zhou

    Background: Fibrous dysplasia (FD) is a rare osseous disorder with limited understanding. This study aimed to evaluate the clinical characteristics of craniofacial FD (CFD) and orbital FD (OFD), explore vision impairment mechanisms, and identify recurrence risk factors. Methods: A retrospective analysis was conducted on 54 CFD patients across three centers, including 30 patients with orbit involved. Results: OFD patients exhibited higher prevalences of polyostotic FD and McCune‐Albright syndrome, and more often underwent debulking rather than radical surgery. Vision impairment was primarily attributed to compressive and stretched optic neuropathy. Polyostotic involvement ( p = 0.034) was a risk factor of subjective recurrence. Surgery age < 16 years ( p = 0.046) and abnormal body mass index ( p = 0.002) were associated with greater postoperative lesion regrowth volume. Conclusions: OFD patients exhibit distinct clinical features. Optic canal decompression is not required for all OFD‐related vision loss patients. Recurrence risk should be thoroughly assessed before surgery.


  • Top Cited Papers
    Open Access

    Evaluating Large Language Models in Ophthalmology: Systematic Review

    by Zili Zhang, Haiyang Zhang, Zhe Pan, Zhangqian Bi, Yao Wan, Xuefei Song, Xianqun Fan

    Background: Large language models (LLMs) have the potential to revolutionize ophthalmic care, but their evaluation practice remains fragmented. A systematic assessment is crucial to identify gaps and guide future evaluation practices and clinical integration. Objective: This study aims to map the current landscape of LLM evaluations in ophthalmology and explore whether performance synthesis is feasible for a common task. Methods: A comprehensive search of PubMed, Web of Science, Embase, and IEEE Xplore was conducted up to November 17, 2024 (no language limits). Eligible publications quantitatively assessed an existing or modified LLM on ophthalmology-related tasks. Studies without full-text availability or those focusing solely on vision-only models were excluded. Two reviewers screened studies and extracted data across 6 dimensions (evaluated LLM, data modality, ophthalmic subspecialty, medical task, evaluation dimension, and clinical alignment), and disagreements were resolved by a third reviewer. Descriptive statistics were analyzed and visualized using Python (with NumPy, Pandas, SciPy, and Matplotlib libraries). The Fisher exact test compared open- versus closed-source models. An exploratory random-effects meta-analysis (logit transformation; DerSimonian-Laird τ2) was performed for the diagnosis-making task; heterogeneity was reported with I2 and subgrouped by model, modality, and subspecialty. Results: Of the 817 identified records, 187 studies met the inclusion criteria. Closed-source LLMs dominated: 170 for ChatGPT, 58 for Gemini, and 32 for Copilot. Open-source LLMs appeared in only 25 (13.4%) of studies overall, but they appeared in 17 (77.3%) of evaluation-after-development studies, versus 8 (4.8%) pure-evaluation studies (P80%), and findings were inconsistent (eg, pooled GPT-3.5>GPT-4). Conclusions: Evidence on LLM evaluations in ophthalmology is extensive but heterogeneous. Most studies have tested a few closed-source LLMs on text-based questions, leaving open-source systems, multimodal tasks, non-English contexts, and real-world deployment underexamined. High methodological variability precludes meaningful performance aggregation, as illustrated by the heterogeneous meta-analysis. Standardized, multimodal benchmarks and phased clinical validation pipelines are urgently needed before LLMs can be safely integrated into eye care workflows.


  • Open Access

    Rituximab for a rare pediatric case of concurrent thyroid eye disease and myasthenia gravis

    by Haiyang Zhang, Ting Lu, Yinwei Li, Haixia Guan, Rebecca S. Bahn, Huifang Zhou

    Rituximab (RTX) is a humanized chimeric anti-CD20 monoclonal antibody that leads to immunosuppression through rapid depletion of B lymphocytes. It has been demonstrated to be useful in treating both thyroid eye disease (TED) and myasthenia gravis (MG), respectively. However, the effectiveness of RTX in concurrent TED and MG cases is unclear and not previously reported in the literature. In this study, we describe a 13-year-old girl who presented with a 10-year history of general MG and a 1-year history of Graves’ disease, bilateral proptosis, eye motility restriction, and lagophthalmos. A comprehensive evaluation confirmed the diagnosis of concurrent TED and MG. Satisfactory effectiveness was observed after RTX treatment without side effects. Based on the described observations, we suggest that RTX should be further explored as a treatment option for patients with concurrent TED and MG.


  • Open Access

    Evaluating Large Language Models in Ophthalmology: Systematic Review (Preprint)

    by Zili Zhang, Haiyang Zhang, Zhe Pan, Zhangqian Bi, Yao Wan, Xuefei Song, Xianqun Fan

    BACKGROUND Large language models (LLMs) have the potential to revolutionize ophthalmic care, but their evaluation practice remains fragmented. A systematic assessment is crucial to identify gaps and guide future evaluation practices and clinical integration. OBJECTIVE This study aims to map the current landscape of LLM evaluations in ophthalmology and explore whether performance synthesis is feasible for a common task. METHODS A comprehensive search of PubMed, Web of Science, Embase, and IEEE Xplore was conducted up to November 17, 2024 (no language limits). Eligible publications quantitatively assessed an existing or modified LLM on ophthalmology-related tasks. Studies without full-text availability or those focusing solely on vision-only models were excluded. Two reviewers screened studies and extracted data across 6 dimensions (evaluated LLM, data modality, ophthalmic subspecialty, medical task, evaluation dimension, and clinical alignment), and disagreements were resolved by a third reviewer. Descriptive statistics were analyzed and visualized using Python (with NumPy, Pandas, SciPy, and Matplotlib libraries). The Fisher exact test compared open- versus closed-source models. An exploratory random-effects meta-analysis (logit transformation; DerSimonian-Laird τ2) was performed for the diagnosis-making task; heterogeneity was reported with I2 and subgrouped by model, modality, and subspecialty. RESULTS Of the 817 identified records, 187 studies met the inclusion criteria. Closed-source LLMs dominated: 170 for ChatGPT, 58 for Gemini, and 32 for Copilot. Open-source LLMs appeared in only 25 (13.4%) of studies overall, but they appeared in 17 (77.3%) of evaluation-after-development studies, versus 8 (4.8%) pure-evaluation studies (P80%), and findings were inconsistent (eg, pooled GPT-3.5>GPT-4). CONCLUSIONS Evidence on LLM evaluations in ophthalmology is extensive but heterogeneous. Most studies have tested a few closed-source LLMs on text-based questions, leaving open-source systems, multimodal tasks, non-English contexts, and real-world deployment underexamined. High methodological variability precludes meaningful performance aggregation, as illustrated by the heterogeneous meta-analysis. Standardized, multimodal benchmarks and phased clinical validation pipelines are urgently needed before LLMs can be safely integrated into eye care workflows.

  • White Matter Alterations of Visual Pathway in Thyroid Eye Disease: A Fixel‐Based Analysis

    by Mengda Jiang, Haiyang Zhang, Yuting Liu, Xuefei Song, Yang Song, Jing Sun, Yan Tang, Ling Zhu, Huifang Zhou, Yinwei Li, et al.

    Background: Thyroid eye disease (TED), particularly its sight‐threatening complication, dysthyroid optic neuropathy (DON), profoundly impacts patients' visual health. The pathological changes in the white matter (WM) fibers within the intracranial visual pathway in TED have been infrequently studied. Understanding these changes holds crucial importance for exploring the pathogenesis and prognosis of TED.Purpose: To utilize fixel‐based analysis (FBA) to clarify the type of microstructural damage occurring in the visual pathway in TED.Study Type: Prospective.Subjects: 28 TED with DON patients (11 males and 17 females), 28 TED without DON (non‐DON) patients (12 males and 16 females), and 28 healthy controls (HCs) (12 males and 16 females).Field Strength/Sequence: 3 T; multishell diffusion MRI using echo planar imaging.Assessment: Fiber density (FD) and fiber‐bundle cross‐section (FC) were calculated to characterize WM microstructural alteration in TED visual pathway. The correlations between FBA metrics and visual field index and mean deviation were examined.Statistical Tests: One‐way analysis of variance, Kruskal–Wallis, t‐tests, Mann–Whitney U, Chi‐square, and Pearson correlation, were conducted with false discovery rate and family wise error corrections. Significance was set at P < 0.05.Results: Both DON and non‐DON groups showed significant FD loss in the right optic tract compared with HCs, with DON patients experiencing more severe FD loss. Only DON patients had FD loss in the right optic radiation (OR) compared with the non‐DON patients and HCs, with no FC difference across groups. FD in DON patients' ORs significantly correlated with visual field index (r = 0.857) and mean deviation (r = 0.751).Data Conclusion: Both DON and non‐DON affect the WM microstructure of the visual pathway to varying extents. Visual field metrics can reflect the severity of FD damage to the OR in the visual pathway of DON patients.Evidence Level: 2.Technical Efficacy: Stage 3.


  • Application of Quantitative MRI in Thyroid Eye Disease: Imaging Techniques and Clinical Practices

    by Haiyang Zhang, Ting Lu, Yuting Liu, Mengda Jiang, Yishi Wang, Xuefei Song, Xianqun Fan, Huifang Zhou

    Thyroid eye disease (TED) is a complex autoimmune disorder that impairs various orbital structures, leading to cosmetic damage and vision loss. Magnetic resonance imaging (MRI) is a fundamental diagnostic tool utilized in clinical settings of TED, for its accurate demonstration of orbital lesions and indication of disease conditions. The application of quantitative MRI has brought a new prospect to the management and research of TED, offering more detailed information on morphological and functional changes in the orbit. Therefore, many researchers concentrated on the implementation of different quantitative MRI techniques on TED for the exploration of clinical practices. Despite the abundance of studies utilizing quantitative MRI in TED, there remain considerable barriers and disputes on the best exploitation of this tool. This could possibly be attributed to the complexity of TED and the fast development of MRI techniques. It is necessary that clinical and radiological aspects of quantitative MRI in TED be better integrated into comprehensive insights. Hence, this review traces back 30 years of publications regarding quantitative MRI utilized in TED and elucidates this promising application in the facets of imaging techniques and clinical practices. We believe that a deeper understanding of the application of quantitative MRI in TED will enhance the efficacy of the multidisciplinary management of TED.Level of Evidence: 2Technical Efficacy: Stage 3